ABCELLERA BIOLOGICS (8QQ) — Financial Flexibility Index
ABCELLERA BIOLOGICS (8QQ) has a Financial Flexibility Index of -0.06x as of December 2025. Free cash flow of €-24.90 Million (operating CF €-34.74 Million minus capex €9.84 Million) represents 0% of total liabilities (€390.05 Million). Check 8QQ strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ABCELLERA BIOLOGICS Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for ABCELLERA BIOLOGICS across 5 annual periods. See working capital position of ABCELLERA BIOLOGICS to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for ABCELLERA BIOLOGICS (2021–2025)
Year-by-year free cash flow to debt coverage for ABCELLERA BIOLOGICS. For the full company profile including market capitalisation, see how much is ABCELLERA BIOLOGICS worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.23x | €-88.52 Million | €-131.29 Million | €390.05 Million | ▼ -129.1% |
| 2024 | -0.10x | €-30.16 Million | €-108.56 Million | €304.47 Million | ▼ -198.9% |
| 2023 | 0.10x | €33.63 Million | €-43.88 Million | €335.78 Million | ▼ -91.2% |
| 2022 | 1.14x | €350.02 Million | €277.36 Million | €307.63 Million | ▲ +9.9% |
| 2021 | 1.03x | €303.04 Million | €244.58 Million | €292.84 Million | — |